Gene-based vaccines from Moderna, Pfizer and its partner BioNTech are drawing early enthusiasm, but investors are hesitant to up stakes because valuations have soared
As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving too quickly. WSJ’s Daniela Hernandez explains. Photo illustration: Laura Kammermann
Yes and why not. Our tax dollars are underwriting most of the cost, yet these companies will want to make a mint selling the cure to us. Socialize the costs but privatize the profits.
WSJ, As of Today 158,975 COVID19 US DEATHS. On the BILLIONS of Tax Payer Dollars the President is spending, are each of these pharmaceutical companies working on a Vaccine that Will cover ALL CURRENT Mutations/Strains of COVID19?
Hydroxychloroquine Useless vaccine
They have a cure already. But because nobody can make money off of it. You can't talk about it or you'll be banned 🚫
follow the money ... never mind inexpensive HCQ
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Debate begins for who's first in line for COVID-19 vaccineU.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. “Not everybody’s going to like the answer,” Dr. Francis Collins, director of the National Institutes of Health, recently told one of the advisory groups the government The first responder and people in the hospital Line up all the Democrats, Bill Gates and his family and Dr.Fauci 🇺🇸😡💉☠️ I am in no rush. People that need it first can have it. I can wait.
Source: YahooNews - 🏆 380. / 59 Read more »
WSJ News Exclusive | If Oxford’s Covid-19 Vaccine Succeeds, Layers of Private Investors Could ProfitThe complex web of investors illustrates the little-known financial interests often at play in the development of scientific innovation—even at institutions like Oxford that seem far removed from mainstream corporate and investing worlds. why is everything a f***** competition on this rock They are working with AstraZeneca, one of the world's leading pharmaceutical companies. Shouldn’t be a competition. It should be a global collaborative effort to bring a free vaccine to market.
Source: WSJ - 🏆 98. / 63 Read more »
Debate begins for who's first in line for COVID-19 vaccineWho will be first in line for a COVID-19 vaccine oh what an appropriate article to be paywalled politicians first👍 No SARS type vaccine is coming, maybe a shot but no vaccine
Source: latimes - 🏆 11. / 82 Read more »
Birx defends herself as Pelosi accuses Trump administration of spreading disinformation on Covid-19Dr. Deborah Birx on Sunday strongly defended her record amid criticism from House Speaker Nancy Pelosi that she doesn't have confidence in the White House coronavirus task force coordinator's handling of the pandemic. drewapp_stifler Is Nancy wrong, though? She’s still a republican
Source: cnnbrk - 🏆 393. / 55 Read more »
How To Clean Your N95 Mask Or Face Covering With Covid-19 CoronavirusFace coverings and masks that can serve as filters should be handled differently. Does the title imply that I should clean my mask with COVID-19 coronavirus? I think I’ll pass 😳 I have a better one: 1. Take it off 2. Spray with alcohol 3. Set it on fire Done! Clean it WITH the virus? Who is even writing Forbes click bait trash these days?
Source: Forbes - 🏆 394. / 53 Read more »
There may never be a 'silver bullet' for COVID-19, WHO warnsThe World Health Organization warned on Monday that, despite strong hopes for a vaccine, there might never be a 'silver bullet' for COVID-19, and the road to normality would be long. WHO is losing our truth Ya valimos Let's revisit this November 4th.
Source: Reuters - 🏆 2. / 97 Read more »